date:May 29, 2014
ent on mice genetically engineered to be unable to produce IL-6, they found that PDX had almost no effect on blood sugar levels.
The mechanism of action described for PDX represents a new therapeutic strategy for improving glucose control, Marette said. Its efficacy may be comparable with that of certain drugs currently prescribed to control glycemia.
Marette now hopes to develop PDX into a diabetes treatment. Together, he and Universite Laval have filed a patent application for the chemical a